mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |